Horizon Pharma reported $3.41B in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Aerie Pharmaceuticals AERI:US USD 302.81M 8.6M
ALKERMES ALKS:US USD 1.05B 7.81M
Amgen AMGN:US USD 24.06B 4.74B
AstraZeneca AZN:LN USD 20.22B 693M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Cara Therapeutics CARA:US USD 186.78M 10.61M
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Eli Lilly And LLY:US USD 17.64B 524.7M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.41B 208.92M
JAZZ PHA JAZZ:US USD 2.57B 19.33M
Novartis NOVN:VX USD 36.95B 1.19B
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Prestige Brands PBH:US USD 336.65M 12.04M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Takeda 4502:JP JPY 2.75T 196.1B
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Valeant Pharmaceuticals VRX:CN USD 4.01B 1.41B
Xeris Pharmaceuticals Inc XERS:US USD 148.92M 12.29M
Zoetis ZTS:US USD 6.55B 100M